EP 3383395 A1 20181010 - COMPATIBLE SOLUTE OR SOLUTE MIXTURE FOR USE IN THE PREVENTION OR TREATMENT OF DISEASES HAVING BARRIER DEFECTS IN EPITHELIAL TISSUES
Title (en)
COMPATIBLE SOLUTE OR SOLUTE MIXTURE FOR USE IN THE PREVENTION OR TREATMENT OF DISEASES HAVING BARRIER DEFECTS IN EPITHELIAL TISSUES
Title (de)
KOMPATIBLES SOLUT ODER SOLUTGEMISCH ZUR VERWENDUNG BEI DER PRÄVENTION ODER BEHANDLUNG VON KRANKHEITEN MIT BARRIEREDEFEKTEN IN EPITHELGEWEBEN
Title (fr)
SOLUTÉ OU MÉLANGE DE SOLUTÉS COMPATIBLE POUR UNE UTILISATION DANS LA PRÉVENTION OU LE TRAITEMENT DE MALADIES À DÉFAUTS DE BARRIÈRE DANS LES TISSUS ÉPITHÉLIAUX
Publication
Application
Priority
- DE 102015121050 A 20151203
- EP 2016079548 W 20161202
Abstract (en)
[origin: WO2017093463A1] The present invention relates to a compatible solute or solute mixture and to a composition containing at least one solute or a solute mixture for use in the prevention or treatment of barrier defects in epithelial tissues associated with at least one bio-based noxa, in particular of diseases comprising at least one barrier defect in at least one cell layer of at least one epithelial tissue, wherein at least one solute is selected from compounds of formula I, formula II, the physiologically acceptable salts of formula I and formula II, the stereoisomeric forms of compounds of formula I, formula II and the physiologically acceptable salts of the stereoisomeric forms or a mixture of at least two of the aforementioned compounds. The at least one compatible solute, solute mixture and/or the composition are provided in the form of a cosmetic, medical device, pharmaceutical product, an addition to any of the aforementioned articles of manufacture or as a constituent of an in-vitro diagnostic product (IVD).
IPC 8 full level
A61K 31/505 (2006.01); A61P 17/16 (2006.01); A61Q 17/00 (2006.01)
CPC (source: EP KR US)
A61K 8/4953 (2013.01 - KR US); A61K 31/505 (2013.01 - EP KR US); A61P 15/00 (2018.01 - EP); A61P 17/00 (2018.01 - EP); A61P 17/16 (2018.01 - KR); A61P 37/08 (2018.01 - US); A61P 39/00 (2018.01 - EP US); A61P 43/00 (2018.01 - EP); A61Q 11/00 (2013.01 - KR US); A61Q 17/00 (2013.01 - US); A61Q 19/007 (2013.01 - KR US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017093463 A1 20170608; CA 3007131 A1 20170608; CN 108601783 A 20180928; DE 102015121050 A1 20170608; DE 202016009058 U1 20211012; EP 3383395 A1 20181010; EP 3834829 A2 20210616; EP 3834829 A3 20210623; JP 2019502668 A 20190131; JP 2021169540 A 20211028; JP 7311266 B2 20230719; JP 7397830 B2 20231213; KR 20180086254 A 20180730; RU 2018123927 A 20200114; US 2018353505 A1 20181213
DOCDB simple family (application)
EP 2016079548 W 20161202; CA 3007131 A 20161202; CN 201680081016 A 20161202; DE 102015121050 A 20151203; DE 202016009058 U 20161202; EP 16805420 A 20161202; EP 21150095 A 20161202; JP 2018528577 A 20161202; JP 2021128930 A 20210805; KR 20187018854 A 20161202; RU 2018123927 A 20161202; US 201615780964 A 20161202